Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
Pasquier F, Sadowsky C, Holstein A, Leterme GLe Prince, Peng Y, Jackson N, Fox NC, Ketter N, Liu E, J Ryan M, et al.